Breast Cancer: Targets and Therapy
Volume 11, 2019 - Issue
Open access
116
Views
2
CrossRef citations to date
0
Altmetric
Clinical Trial Report
Efficacy and tolerability of BP-C1 in metastatic breast cancer: a Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study
Kritiya Butthongkomvong1 Udonthani Cancer Hospital, Udonthani, Thailand
, Nilubol Raunroadroong2 Lampang Cancer Hospital, Lampang, Thailand
, Sirikul Sorrarichingchai2 Lampang Cancer Hospital, Lampang, Thailand
, Isaraporn Sangsaikae3 Ubonratchathani Cancer Hospital, Ubonratchathani, Thailand
, Vichien Srimuninnimit4 Division of Medical Oncology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
, Henrik Harling5 Bispebjerg University Hospital, Department of Gastroenterology, Center for Digestive Disease, Copenhagen, Denmark
& Stig Larsen6 Digestive Disease Center, Centre for Epidemiology and Biostatistics, Norwegian University of Life Sciences, Oslo, Norway, [email protected]Correspondence[email protected]
show all
Pages 43-51
|
Published online: 14 Jan 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.